Literature DB >> 33132383

PTPN11 mutations are associated with poor outcomes across myeloid malignancies.

David M Swoboda1, Najla Al Ali2, Onyee Chan2, Eric Padron2, Andrew T Kuykendall2, Jinming Song3, Mohammad Hussaini3, Chetasi Talati2, Kendra Sweet2, Jeffrey E Lancet2, David A Sallman2, Rami S Komrokji2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33132383     DOI： 10.1038/s41375-020-01083-3

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.

Authors:  Sebastian Stasik; Jan-Niklas Eckardt; Michael Kramer; Christoph Röllig; Alwin Krämer; Sebastian Scholl; Andreas Hochhaus; Martina Crysandt; Tim H Brümmendorf; Ralph Naumann; Björn Steffen; Volker Kunzmann; Hermann Einsele; Markus Schaich; Andreas Burchert; Andreas Neubauer; Kerstin Schäfer-Eckart; Christoph Schliemann; Stefan Krause; Regina Herbst; Mathias Hänel; Norbert Frickhofen; Richard Noppeney; Ulrich Kaiser; Claudia D Baldus; Martin Kaufmann; Zdenek Rácil; Uwe Platzbecker; Wolfgang E Berdel; Jiri Mayer; Hubert Serve; Carsten Müller-Tidow; Gerhard Ehninger; Martin Bornhäuser; Johannes Schetelig; Jan M Middeke; Christian Thiede
Journal:  Blood Adv       Date:  2021-09-14

2.  CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis.

Authors:  Xinmin Zhang; Cristina Ghiuzeli; Erin Jou; Peihong Hsu; Jonathan Kolitz; Judith P Brody
Journal:  Leuk Res Rep       Date:  2022-06-25

3.  Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.

Authors:  Sydney Fobare; Jessica Kohlschmidt; Hatice Gulcin Ozer; Krzysztof Mrózek; Deedra Nicolet; Alice S Mims; Ramiro Garzon; James S Blachly; Shelley Orwick; Andrew J Carroll; Richard M Stone; Eunice S Wang; Jonathan E Kolitz; Bayard L Powell; Christopher C Oakes; Ann-Kathrin Eisfeld; Erin Hertlein; John C Byrd
Journal:  Blood Adv       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.